PetIQ (NASDAQ:PETQ) Sets New 1-Year High at $30.53

Shares of PetIQ, Inc. (NASDAQ:PETQ) reached a new 52-week high during mid-day trading on Wednesday . The stock traded as high as $30.53 and last traded at $30.45, with a volume of 2113977 shares. The stock had previously closed at $20.57.

Analyst Upgrades and Downgrades

Separately, Benchmark restated a “buy” rating and set a $30.00 price objective on shares of PetIQ in a report on Friday, May 10th. Four equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, PetIQ currently has a consensus rating of “Buy” and an average price target of $29.00.

PetIQ Stock Up 48.0 %

The firm has a 50-day simple moving average of $21.74 and a 200 day simple moving average of $19.18. The company has a debt-to-equity ratio of 1.84, a current ratio of 2.42 and a quick ratio of 1.25. The company has a market capitalization of $905.65 million, a PE ratio of 138.27 and a beta of 1.71.

PetIQ (NASDAQ:PETQ) last released its quarterly earnings data on Wednesday, May 8th. The company reported $0.51 EPS for the quarter, beating the consensus estimate of $0.34 by $0.17. PetIQ had a return on equity of 13.33% and a net margin of 0.66%. The company had revenue of $308.44 million for the quarter, compared to analyst estimates of $302.16 million. On average, research analysts predict that PetIQ, Inc. will post 1.1 EPS for the current fiscal year.

Insider Transactions at PetIQ

In other news, Director Scott Huff sold 12,117 shares of PetIQ stock in a transaction dated Wednesday, June 12th. The stock was sold at an average price of $22.19, for a total transaction of $268,876.23. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 9.62% of the company’s stock.

Institutional Trading of PetIQ

A number of hedge funds and other institutional investors have recently modified their holdings of the business. CWM LLC grew its stake in PetIQ by 86.2% in the second quarter. CWM LLC now owns 1,251 shares of the company’s stock worth $28,000 after purchasing an additional 579 shares in the last quarter. ICA Group Wealth Management LLC acquired a new position in PetIQ in the fourth quarter worth about $35,000. First Horizon Advisors Inc. acquired a new position in PetIQ in the second quarter worth about $36,000. FinTrust Capital Advisors LLC grew its stake in PetIQ by 50.2% in the first quarter. FinTrust Capital Advisors LLC now owns 2,618 shares of the company’s stock worth $48,000 after purchasing an additional 875 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale acquired a new position in PetIQ in the fourth quarter worth about $50,000. 94.99% of the stock is owned by hedge funds and other institutional investors.

About PetIQ

PetIQ, Inc operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats.